Endologix Inc (ELGX)

13.84
0.16 1.10
NASDAQ : Health Care
Prev Close 14.00
Open 14.00
Day Low/High 13.79 / 14.04
52 Wk Low/High 6.50 / 14.89
Volume 66.51K
Avg Volume 1.33M
Exchange NASDAQ
Shares Outstanding 81.82M
Market Cap 1.13B
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Endologix (ELGX) Highlighted As Weak On High Volume

Endologix (ELGX) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Endologix (ELGX) as a weak on high relative volume candidate

Endologix (ELGX) Is Today's Strong On High Volume Stock

Endologix (ELGX) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Endologix (ELGX) as a strong on high relative volume candidate

Analysts' Actions -- Agios Pharma, Concho Resources, Occidental, Sprouts and More

Analysts' Actions -- Agios Pharma, Concho Resources, Occidental, Sprouts and More

Here are Monday's top research calls, including upgrades for Agios Pharmaceuticals and Concho Resources, and downgrades for Occidental Petroleum and Sprouts Farmers Market.

Endologix Reports Positive Clinical Data On The Nellix EVAS System From A Multicenter Study In Italy

Endologix Reports Positive Clinical Data On The Nellix EVAS System From A Multicenter Study In Italy

Results Presented at 2016 Society of Vascular Surgery Annual Meeting

Insider Trading Alert - ELGX, SGEN And JYNT Traded By Insiders

Insider Trading Alert - ELGX, SGEN And JYNT Traded By Insiders

Stocks with insider trader activity include ELGX, SGEN and JYNT

Endologix (ELGX) Is Today's Strong On High Volume Stock

Endologix (ELGX) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Endologix (ELGX) as a strong on high relative volume candidate

Endologix Reports Positive Clinical Data From The Nellix EVAS FORWARD-IDE Study

Endologix Reports Positive Clinical Data From The Nellix EVAS FORWARD-IDE Study

EVAS FORWARD-IDE Meets Primary and Secondary Endpoints; Additional Data to be Presented at SVS Meeting on June 11

Commit To Buy Endologix At $10, Earn 24.1% Annualized Using Options

Commit To Buy Endologix At $10, Earn 24.1% Annualized Using Options

Investors eyeing a purchase of Endologix Inc. stock, but tentative about paying the going market price of $11.00/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Bullish Two Hundred Day Moving Average Cross - ELGX

Bullish Two Hundred Day Moving Average Cross - ELGX

In trading on Tuesday, shares of Endologix Inc. crossed above their 200 day moving average of $10.81, changing hands as high as $10.87 per share.

Endologix (ELGX): Today's Weak On High Volume Stock

Endologix (ELGX): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Endologix (ELGX) as a weak on high relative volume candidate

Endologix is Now Oversold (ELGX)

Endologix is Now Oversold (ELGX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Endologix, Inc. And TriVascular Technologies, Inc. Complete Merger

Endologix, Inc. And TriVascular Technologies, Inc. Complete Merger

Endologix Treats 5,000 AAA Patients with Nellix® Endovascular Aneurysm Sealing System

ELGX: Insiders vs. Shorts

ELGX: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 01/15/2016 settlement date, and Endologix Inc. is one of the most shorted stocks of the Russell 3000, based on 15.24 "days to cover" versus the median component at 4.77.

First Week of March 18th Options Trading For Endologix (ELGX)

First Week of March 18th Options Trading For Endologix (ELGX)

Investors in Endologix Inc. saw new options begin trading this week, for the March 18th expiration.